Auxilium Pharmaceuticals, Inc. Earnings Conference Call (Q1 2008)  Today's Calls

Visit the TF Network Sites· Corporate IR Center · Institutional Investor Center · Individual Investor Center Download Plug-In Real Player 8 Basic Windows Media Player Other Conference Calls Other Apr 30 Calls Today's Calls

Call Details Auxilium Pharmaceuticals, Inc. Earnings Conference Call (Q1 2008) Wed, Apr 30, 2008, 10:00 am Eastern Listen to the archived event audio About Auxilium Pharmaceuticals, Inc. (NasdaqGM:AUXL) Auxilium Pharmaceuticals, Inc., a specialty biopharmaceutical company, focuses on developing and marketing products to urologists, endocrinologists, orthopedists, and select primary care physicians primarily in the United States. It markets Testim, a topical 1% testosterone gel, for the treatment of hypogonadism. The company’s product pipeline includes XIAFLEX, an injectable collagenase enzyme, which is in Phase III of development for the treatment of Dupuytren’s contracture; and in Phase II of development for the treatment of Peyronie’s Disease and Frozen Shoulder Syndrome. Its product pipeline also comprises AA4010, which is in Phase I of development for the treatment of overactive bladder using its transmucosal film delivery system. In addition, the company is developing one pain product, which is in preclinical stage using its transmucosal film delivery system. Further, it has rights to seven additional pain products, and products for hormone replacement and urologic disease using its transmucosal film delivery system, and options to indications using AA4500 for non-topical formulations. The company was founded in 1999 and is headquartered in Malvern, Pennsylvania. More Info: Quote | Chart | Profile | Reports | Research | Msgs | Insider | Financials | Analyst Ratings